LEILA LEDESMA-APOLINARIO: Open Payments
NPI 1255988432 · HOBOKEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,516 in 67 payments from 12 companies in 2025. Trend: 2023 $276 · 2024 $1,636 · 2025 $1,516
Food & beverage: $1,516
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 13 | $343 |
| Janssen Biotech, Inc. | 15 | $338 |
| Phathom Pharmaceuticals, Inc. | 9 | $318 |
| Ardelyx, Inc. | 14 | $216 |
| ABBVIE INC. | 5 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $73 |
| Novo Nordisk Inc | 2 | $55 |
| Lilly USA, LLC | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $18 |
Products named: REZDIFFRA, TREMFYA, VOQUEZNA, IBSRELA, ENTYVIO, Wegovy, VIBERZI, CREON.
Industry payments across NJ — which companies pay providers there.
